Question 1

What is YourChoice Therapeutics?

Accepted Answer

YourChoice Therapeutics is a Entity.

Question 2

How often does YourChoice Therapeutics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was YourChoice Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Apr 07, 2026.

Question 4

When was YourChoice Therapeutics last mentioned in news?

Accepted Answer

Last active on Apr 09, 2026.

Question 5

What is YourChoice Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 30 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is YourChoice Therapeutics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving YourChoice Therapeutics?

Accepted Answer

Cornell Male Contraception Breakthrough (Apr 07, 2026, 7 articles).

Question 8

How did the "Cornell Male Contraception Breakthrough" event impact YourChoice Therapeutics?

Accepted Answer

YourChoice Therapeutics is developing YCT-529, a hormone-free male contraceptive pill that has completed its first safety trial in humans, operating through a different mechanism than the Cornell University research.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.